Canonical: https://ownershiptrace.com/13f/companies/198

# Who owns Lyell Immunopharma, Inc. (LYEL)? Elite investor 13F holders

2 tracked elite investors reported holding Lyell Immunopharma, Inc as of 2026-06-30, including Alphabet, Renaissance Technologies LLC. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

2 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The company's lead product candidate include rondecabtagene autoleucel, an autologous dual-targeting CD19/CD20 CAR T-cell therapy in development, which is in pivotal PiNACLE trial in the 3L+ setting and in…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Alphabet](https://ownershiptrace.com/13f/investors/86) | LYELL IMMUNOPHARMA INC | SHARE | 2026-06-30 | 2026-08-07 00:00:00 | 4120247.00 USD | 293256.000000 | Shares | hold | [Original filing](https://www.sec.gov/Archives/edgar/data/1652044/0001652044-26-000073-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | LYELL IMMUNOPHARMA INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 1829169.00 USD | 130190.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)